TM4SF1 and melanoma: Experiments conducted in mice showed that the chL6 antibody caused antibody-dependent cellular cytotoxicity at a significantly lower concentration than that required for the mouse and it was even effective against melanoma expressing low levels of TM4SF1 (Liu et al., 1987).